company update - enseval€¦ · • established in october 1973 with the aim of managing the...

COMPANY UPDATEPT ENSEVAL PUTERA MEGATRADING TBKEnded Sept 30, 2017 (Unaudited)

TABLE OF CONTENT

SECTION 1 ENSEVAL IN BRIEF 3

SECTION 2 BUSINESS OVERVIEW 8

SECTION 3 OPERATIONAL OVERVIEW 20

SECTION 4 FINANCIAL OVERVIEW 23

SECTION 5 2017 OVERVIEW 28

ENSEVAL IN BRIEF

• Established in October 1973 with the aim of managing the distribution function because of theseparation of the distribution division from the marketing and production division of PT KalbeFarma;

• On 1 August 1994, the Company listed its shares on the Jakarta Stock Exchange;• The Company focuses its activities on distribution and trading services under 5 divisions:

• Pharmaceutical products sales and distribution, which comprised of patented medicines aswell as generic medicines;

• Consumer products, non prescription medicine and nutrition sales and distribution;• Medical equipment sales and distribution, which include marketing activities;• Raw material sales and distribution, which include veterinary product;• Healthcare services.

Integrated healthcare Distribution and Logistic services company through Service Excellence, Technology Driven and Strong Leadership.

4

1973 – Incorporationof PT Enseval

1988 – Incorporationof PT Arya GuptaCempaka

1993 – PT Arya GuptaCempaka changed its name toPT Enseval PuteraMegatrading

1994 – PT Enseval PuteraMegatrading Tbk conductedits Initial Public Offering

2003 – Incorporationof PT MilleniaDharma Insani

2007 – Incorporation of PTEnseval Medika Prima andPT Global ChemindoMegatrading

2008 – Incorporation of PTRenalmed Tiara Utama

2011 – The CompanyRight Issue to financeexpansion

2012 – Obtained ISO9001:2008certification

2014 – Incorporation of PT Medika Renal Citraprima.

2016 – Renewed GDP certification, ISO 9001: 2008 & OHSAS 18001: 2007.

More than 40 years in business, Enseval constanly makes the best effort to obtain sustainable growth.

ENSEVAL IN BRIEF

5

ENSEVAL IN BRIEF

• Currently, the Company owns and operates 47 branches and 28 branches under subsidiaries and 29 salesoffices located on Indonesia archipelago;

• The Company also owns 2 Regional Distribution Centers (RDC) located in Jakarta and Surabaya;• For the information technology platform, the Company now is using Oracle E-Business Suite Release 12;• Until the end of September 2017, the Company's operation supported by over than 5,000 employees.

Become Market Leader Through high quality of information Technology systemand competent human resources.

6

AWARDS UNTIL SEPT 2017

2017 OVERVIEW

• INFOBANK - 100 Fastest Growing Company Awards 2017.

• INDONESIAN HUMAN CAPITAL STUDY 2017.

• FRONTIER - The Best Building and Managing Corporate Image.– PHARMACEUTICAL DISTRIBUTOR.

– MEDICAL EQUIPMENT DISTRIBUTOR.

• ORACLE - EXA Trend-Setter Award.

• FROST & SULLIVAN - Indonesia Pharmaceutical Distributor of the year.

• Department of Animal Husbandry in East Java province - the best distributor of veterinary drug.

• HERMINA HOSPITAL GROUP - The Best Pharmaceutical Distributor.

• BETHESDA HOSPITAL YOGYAKARTA - The Best Pharmaceutical Distributor.

• NIVEA - The Best Weighted Distributor.

• Rekor Bisnis Indonesia - Pharmaceutical Distributor with the Most Outlet Coverage.

• The Most Powerful Distribution Performance– EXTRA JOSS

– KOMIX

7

• AZ/NZS ISO 9001:2008 Certified

• BS OHSAS 18001:2007 Certified

• Good Distribution Practices Certified (GDP)

• 41 branches, Cara Distribusi Obat yang Baik (CDOB Certified)

SERTIFICATION

2017 OVERVIEW

8

*Description of net sales per products as describe below :

BUSINESS OVERVIEW

NET SALES PER PRODUCTS UNTIL SEPT 30, 2017

Products Portfolio Net Sales (Rp)Contribution to

Total Net Sales (%)

Consumer Products 6.245.609.458.553 42,88%

Prescription Medicine 4.026.010.642.481 27,64%

Non Prescription Medicine 2.314.255.850.472 15,89%

Raw Materials for Sale 1.103.878.791.761 7,58%

Medical Equipment 842.020.090.823 5,78%

Veterinary Products 26.801.806.993 0,19%

Health Care Services 6.002.360.547 0,04%

Total : 14.564.579.001.630 100,00%

10

BUSINESS OVERVIEW

DESCRIPTION OF NET SALES PER PRODUCTS AND THE CONTRIBUTION

42,88%27,64%

15,89%

7,58%

5,78% 0,19% 0,04%Consumer Products

Prescription Medicine

Non Prescription Medicine

Raw Materials for Sale

Medical Equipment

Veterinary Products

Health Care Services

Net SalesSeptember 2017

Rp14.564,58 billion

11

*Growth of net sales per products as describe below :

BUSINESS OVERVIEW

ALL BUSINESS LINE OF THE COMPANY WERE GREW SIGNIFICANTLY

Products Portfolio Net Sales Sep 2017 (Rp) Net Sales Sep 2016 (Rp) Growth %

Consumer Products 6.245.609.458.553 6.070.637.256.423 2,88%

Prescription Medicine 4.026.010.642.481 3.743.517.742.077 7,55%

Non Prescription Medicine 2.314.255.850.472 2.259.833.128.339 2,41%

Raw Materials for Sale 1.103.878.791.761 1.056.189.703.284 4,52%

Medical Equipment 842.020.090.823 779.445.923.756 8,03%

Veterinary Products 26.801.806.993 25.197.432.294 6,37%

Health Care Services 6.002.360.547 5.335.782.616 12,49%

Total : 14.564.579.001.630 13.940.156.968.789 4,48%

12

Total ConsumerProducts

PrescriptionMedicine

Non PrescriptionMedicine

Raw Materials forSale

Medical Equipment VeterinaryProducts

Health CareServices

Sep-16 Sep-17

BUSINESS OVERVIEW

GROWTH OF NET SALES Sept 2016 VS Sept 2017

4,48%

13

2,88%

7,55%

2,41%

4,52% 8,03%6,37% 12,49%

BUSINESS OVERVIEW

THE COMPANY’S PRINCIPALS

Non-Prescription

Prescription

Consumer – Health – Beauty

14

BUSINESS OVERVIEW

THE COMPANY’S PRINCIPALS | MEDICAL DEVICE & DIAGNOSTIC

15

BUSINESS OVERVIEW

THE COMPANY’S PRINCIPALS | RAW MATERIALS

16

RDC JAKARTARDC SURABAYA47 BRANCH27 BRANCH under subsidiaries (TSJ)29 SALES OFFICE

BUSINESS OVERVIEWNATIONAL COVERAGE 74 FULL SERVICES BRANCHES & MORE THAN 200,000 DIRECT OUTLET COVERAGE

17

Type of outlet coveraged by the company’s distribution

Covers all trade channels in the market :

BUSINESS OVERVIEW

MORE THAN 200,000 DIRECT OUTLET COVERAGE

General / Traditional Trade Channel

• Wholesalers

• Retailers

• Provision Stores

• Convenience Stores

• Food & Beverage

• Store - Fruit Shops

• Cosmetic Stores

• etc

Modern Trade Channel

• Hypermarkets

• Supermarkets

• Mini Markets

• Departement Stores

• etc

Pharmaceutical Trade Channel

• Pharmacies

• Drugstores

• Hospitals

• Labs – Clinics

• Institutions

• etc

18

2017 OVERVIEW

SALES CONTRIBUTION BY CHANNEL (Sept 2016 VS Sept 2017)

35,86%

45,30%

18,84%

2017

Pharmaceutical Trade General Trade

Modern Trade

36,58%

43,37%

20,04%

2016

Pharmaceutical Trade General Trade

Modern Trade

19

2017 OVERVIEW

SALES CONTRIBUTION BY PRINCIPAL (Sept 2016 VS Sept 2017)

27%

73%

2016

External Principal Internal Principal

27%

73%

2017

External Principal Internal Principal

20

BUSINESS OVERVIEW

THE COMPANY’S MODERN TRADE ACCOUNT

21

BUSINESS OVERVIEW

200,000+ DIRECT OUTLET COVERAGE

Pharmacy; 11.571

Hospital; 1.614

Drugstore; 4.485

Wholesaler; 2.260

Hypermarket, 178

Supermarket; 1.179

Minimarket; 3.115

Provision Store; 162.000

F&B Stores; 15.000

Cosmetics; 1.750

Others; 9.800

Covers all trade channels in the market:

- General / Traditional Trade Channel: Wholesalers, Retailers, Provision Stores, Convenience Stores, Food & Beverage Stores, Fruit Shops, Cosmetics Stores, etc

- Modern Trade Channel: Hypermarkets, Supermarkets, Mini Markets, Department Stores, etc

- Ethical Trade Channel: Pharmacies, Drugstores, Hospitals, Labs - Clinics, Institutions, etc

22

OPERATIONAL OVERVIEW

Mobile application (Tablet Computer & PDA)

- Supervisor: Team Performance Analysis.

- Salesman & Deliveryman: Faster Order Taking & Faster Information Process.

Global Information System (GIS)

- Application for more in depth sales and territory mapping.

Supported by Enseval Customer Care (ECC) – HOTLINE 1500095

In Branches Order Management, Complaint Handling, Basic Product Information.

Customers also can reach Enseval office via Phone, Fax & Email for easy customer ordering.

IT INFRASTRUCTURE

25


Centralized IT system using Oracle E-Business Solutions• Integrated & Real Time system

Use the best world-class ERP system by Oracle Complete Oracle E-Business SuiteOracle Warehouse Management System (WMS)Advance Supply Chain Planning (ASCP) and Oracle Demantra

Tablet Computer & PDA system E-Mobile ®2,300+ PDA used by Supervisors, Salesmen, Deliverymen, & Collectors Menu: Distribution Plan, Distribution Achievement, Overdue, etc

Provide data security for antivirus by Trend Micro and Sonic Wall

IT INFRASTRUCTURE

26


• ENI (Enseval Net Info) • Web based application

• Sales (hourly updated) & Stock (D-1)

• EXI (Enseval Xpress Info)• SMS based application

• Sales & Stock Report

• ERI (Enseval Raw Data Info)• Raw Data format, distribution and logistics information activities

• ENO (Enseval NET Order)

• EMOS (Enseval Mobile Order System)

• Online order with business-to-business system

For Principal

For Customer

COMPREHENSIVE BUSINESS ACCESS

27

FINANCIAL OVERVIEW

NET SALES GROWTH

13.940,16

12.395,13

14.564,58

13.050,84

2016 2017

88,92%89,61%

0,69%

4,48%

5,29%

: Net Sales in Rp/billion : COGS in Rp/billion

: Net Sales in Rp/billion : COGS in Rp/billion

: COGS Margin

Net Sales COGS

Sept 30, 2016 (Unaudited)




29

1.545,02

1.513,74

FINANCIAL OVERVIEW

EXPENSE RATIO

(2,02)%


Sept 30, 2017(Unaudited)

Gross Profit

Gross Profit Margin

Gross Profit (Rp/billion)

11,08%10,39%

(0,69)%

1.105,20

1.108,37

0,29%



Operational Expense

Operational Expense Margin

Operational Expense (Rp/billion)

7,93%7,61%

(0,32)%

30

FINANCIAL OVERVIEW

PROFIT GROWTH (Sept 2016 VS Sept 2017)

439,82 496,21377,10405,37 443,82

337,80

(7,83)% (10,56)%

(10,42)%

Operating Profit Margin Income Before Tax Expense Margin

Income For The Period Margin







3,16% 2,78%(0,38)%

Operating Profit(Rp/billion)

Income Before Income Tax Expense (Rp/billion)

Operating Profit Income BeforeIncome Tax Expense

Income For The Period

3,56% 3,05%(0,51)%

2,71% 2,32%(0,39)%

31

FINANCIAL OVERVIEW

FINANCIAL POSITION (Dec 2016 VS Sep 2017)

7.087,27

2.467,29

4.619,98

7.180,07

2.226,54

4.953,54

1,31%

(9,76)%

7,22%

Dec 31, 2016 (Audited)


Total Assets (Rp/billion) Total Liabilities (Rp/billion)





32

WAREHOUSE MANAGEMENT SYSTEM-Oracle-based WMS

-Manage stock from

inbound-outbound, by location, SKU, Batch Number, Expiry Date.

-Bar-coding system with mobile bar-code reader to eliminate duplication & increase accurate operation.

34

COLD CHAIN MANAGEMENT-Enseval has implemented and Standardized Cold Chain Management in it’s RDC, Branch Warehouse, and Transportation according to ISO 9001:2008.

-Cold Chain Management is performed with close control

-All activities is always recorded and stored properly

Cold Chain Handling in Enseval Delivery with Temperature Controlled Transportation

Temperature MonitoringDocument

35

STANDARDIZED FACILITIESSTANDARDIZED BRANCHES (FULL SERVICES)

36

STRATEGIC VALUE TO BUSINESS PARTNERS• Strong product portfolio.

• Sustainable business growth.

• Supported by 2 RDC, 47 branches, 29 Sales Office & 200,000+ direct coverage outlets.

Market Leading Position in Indonesia

• 40+ years of strategic expertise in distribution and logistics service.

• Strong and good relationship with all business players : Principals & Outlets.

• Having in aggregate over 100 years of experience senior management team and supported by more than 5,000 employees.

Reliable Partner to Grow

• Public listed company with professional management that treats all business partners equally with the utmost transparency and accountability.

• Independent business entity with neutrality to ensure fairness to all stakeholders.Transparency and Neutrality

• Robust balance sheet figures.

• Solid financial performance.Strong Financial Track Record

• Commitment to assist & support Principal to achieve it’s goals.

• Implementation of Continuous Improvement (CONIM) in all business aspects by Enseval’s employees in every level.

Enseval’s Commitment Towards Improvement

37

THANK YOUFor Further Information:

Corporate SecretaryPT Enseval Putera Megatrading Tbk.Enseval BuildingKawasan Industri PulogadungJalan Pulolentut No. 10Jakarta 13920 – IndonesiaPhone : 62-21-46822422 Fax : 62-21-4609039Website : www.enseval.comEmail : [email protected]

FORWARD LOOKING STATEMENTThis presentation has been prepared for informational purposes only by PT Enseval Putera Megatrading Tbk. ("Enseval" or the "Company")

This presentation has been prepared solely for use in connection with the release 0f 30 Sept 2017 (unaudited) results of the Company. The informationcontained in this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and noreliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. None of the Company orany of their respective affiliates, and their respective commissioners, directors and employees, advisors or representative shall have any liability whatsoever (innegligence or otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with the presentation.Any decision to purchase or subscribe for securities of the Company should not be made on the basis of the information contained in this presentation.The presentation is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or anexemption from registration.This presentation and its contents are confidential unless they are become generally avaiable as public information in accordance with prevailing lawsregulations (other than as a result of a disclosure by you) and must not be distributed, published or reproduced (in whole or in part) or disclosed by receipentsto any other person. This presentation does not constitute a recommendation regarding the securities of the Company.This presentation, including the information and opinions contained herein, is provided as the date of this presentation and is subject to change without notice,including change as a result of the issuance of 30 Sept 2017 unaudited results of the Company.This presentation includes "forward-looking statements". These statements contain the words "anticipate", "believe", "intend", "estimate", "expect" and wordsof similiar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding theCompany's financial position, business strategy, plans and objectives of management for future operations (including development plans, objectives relating tothe Company's products and services and anticipated product launches) are forward-looking statements. Such forward-looking statements are based onnumerous assumptions regarding the Company's present and future business strategies and the environment in which of the Company will operate in thefuture. These forward-looking statements speak only ast the date of this presentation. The Company expressly disclaims any obligation or reflection of anychange in the Company's expectations with regard thereto, or any change in events, conditions or circumtances on which any statements is based.Market data and certain industry forecast used in this presentation were obtained from market research, publicity avaiable information and industrypublications which have not been independently verified, and no presentation is made as to the accuracy of such information.

company update - enseval€¦ · • established in october 1973 with the aim of managing the...

Documents